Save time and get answers to complex questions with AI chat
When will a generic version of xiaflex be available?Brenzavvy discontinuation?Xenazine current manufacturer 2025?Excipients list used in dexamethasone creams?Bortezomib market france?
See the DrugPatentWatch profile for Synagis
Synagis is the brand name for palivizumab. [1]
Palivizumab is a monoclonal antibody used to help prevent respiratory syncytial virus (RSV) infection in certain high-risk children. [1]
The information provided here identifies Synagis’s generic name as palivizumab. If you’re looking for whether an FDA-approved generic (or biosimilar) version exists and where, you may need to check current availability and approval status by regulator and market. [1]
1
Other Questions About Synagis :